Journey Medical (DERM) Research & Development (2021 - 2025)

Journey Medical has reported Research & Development for 5 years, with the latest figure at $154000.0 in Q4 2025.

• For the quarter ending Q4 2025, Research & Development fell 29.36% year-over-year to $154000.0; the trailing twelve-month figure through Dec 2025 stood at $480000.0 (down 95.13% YoY), and the FY2025 full-year result was $480000.0, down 95.13% from the prior year.
• Research & Development for Q4 2025 stood at $154000.0, down from $287000.0 in the prior quarter.
• The five-year high for Research & Development was $7.9 million in Q1 2024, with the low at $29000.0 in Q2 2021.
• Historically, Research & Development has averaged $1.8 million across 5 years, with a median of $1.4 million in 2022.
• Annual changes were most pronounced in 2022 — Research & Development jumped 8896.55% — and 2025, when it tumbled 99.51%.
• Journey Medical's Research & Development stood at $2.0 million in 2021, then jumped by 113.65% to $4.3 million in 2022, then sank by 64.64% to $1.5 million in 2023, then tumbled by 85.51% to $218000.0 in 2024, then retreated by 29.36% to $154000.0 in 2025.
• The last three Research & Development figures came in at $154000.0 (Q4 2025), $287000.0 (Q3 2025), and $39000.0 (Q1 2025), per Business Quant data.